| 日期 | 主要股東
| 每股
平均價 | 類型 | 買/賣或涉及
股份數目 | 變動股數
佔已發行股(%) | 目前持股量 | 佔已
發行股(%) |
| 2021-06-18 | 郭華清 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | 郭華清 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | 王華茂 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | 郭炳森 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | 李宗海 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | China Medmaterial Limited 鴻創醫學有限公司 | | 1701 (L) | 39,894,706(L) | N/A | 39894706(L) | 7.03(L) |
| 2021-06-18 | Applied Biomaterial Ltd. | | 1701 (L) | 39,894,706(L) | N/A | 39894706(L) | 7.03(L) |
| 2021-06-18 | BVCF Realization Fund, L.P. | | 1701 (L) | 39,894,706(L) | N/A | 39894706(L) | 7.03(L) |
| 2021-06-18 | BVCF Realization Fund GP, Ltd. | | 1701 (L) | 39,894,706(L) | N/A | 39894706(L) | 7.03(L) |
| 2021-06-18 | YIJIE Biotech Holding Limited 益傑生物技術控股有限公司 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | Quanzhou Dingwo Chuangfeng Investment Center (Limited Partnership) 泉州市鼎沃創豐投資中心(有限合夥) | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | Yeed Holdings Limited 儀德控股有限公司 | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | Accure Biotech Limited | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | Candock Holdings Limited | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |
| 2021-06-18 | He Xi Holdings Limited | | 1701 (L) | 215,123,753(L) | N/A | 215123753(L) | 37.92(L) |